Switch to:
Biomarin Pharmaceutical Inc (NAS:BMRN)
EV/Revenue
13.19 (As of Today)

EV/Revenue ratio is calculated as enterprise value divided by its revenue. As of today, Biomarin Pharmaceutical Inc's enterprise value is $13,780 Mil. Biomarin Pharmaceutical Inc's revenue for the trailing twelve months (TTM) ended in Sep. 2016 was $1,045 Mil. Therefore, Biomarin Pharmaceutical Inc's EV/Revenue ratio for today is 13.19.

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV/Revenue is a similar ratio to P/S Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today, Biomarin Pharmaceutical Inc's stock price is $82.21. Biomarin Pharmaceutical Inc's revenue per share for the trailing twelve months (TTM) ended in Sep. 2016 was $6.40. Therefore, Biomarin Pharmaceutical Inc's P/S Ratio for today is 12.84.


Definition

EV/Revenue is a similar ratio to P/S Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Biomarin Pharmaceutical Inc's EV/Revenue for today is calculated as:

EV/Revenue=Enterprise Value (Today)/Revenue (TTM)
=13779.922/1044.699
=13.19

Biomarin Pharmaceutical Inc's current Enterprise Value is $13,780 Mil.
Biomarin Pharmaceutical Inc's Revenue for the trailing twelve months (TTM) ended in Sep. 2016 was 227.936 (Dec. 2015 ) + 236.736 (Mar. 2016 ) + 300.131 (Jun. 2016 ) + 279.896 (Sep. 2016 ) = $1,045 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Biomarin Pharmaceutical Inc's P/S Ratio for today is calculated as:

P/S Ratio=Share Price (Today)/Revenue Per Share (TTM)
=82.21/6.404
=12.84

Biomarin Pharmaceutical Inc's share price for today is $82.21.
Biomarin Pharmaceutical Inc's Revenue Per Share for the trailing twelve months (TTM) ended in Sep. 2016 was 1.424 (Dec. 2015 ) + 1.465 (Mar. 2016 ) + 1.846 (Jun. 2016 ) + 1.669 (Sep. 2016 ) = $6.40.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Related Terms

Enterprise Value, Revenue, P/S Ratio


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Biomarin Pharmaceutical Inc Annual Data

Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13Dec14Dec15
ev2rev 17.1627.556.026.458.199.2912.1618.1517.5719.09

Biomarin Pharmaceutical Inc Quarterly Data

Jun14Sep14Dec14Mar15Jun15Sep15Dec15Mar16Jun16Sep16
ev2rev 14.2915.9417.5724.6225.5919.0819.0914.7213.2214.13
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK